✦ LIBER ✦

Atropine for therapy refractory acute coronary spasm

✍ Scribed by Stefan Verheye; Paul Vermeersch

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 19 KB
Volume: 50
Category: Article
ISSN: 1522-1946
DOI: 10.1002/1522-726x(200007)50:3<::aid-ccd24>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Coronary stenting for coronary vasospasm

Coronary stenting for coronary vasospasm refractory to medical therapy

✍ Andrew Burns; Yuvaraj Malaiapan; Ian Meredith 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Salvage coronary angioplasty for symptom

Salvage coronary angioplasty for symptoms refractory to medical therapy

✍ Feldman, Robert L. ;Macdonald, Robert G. ;Hill, James A. ;Carmichael, Michael J. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Bone marrow transplantation for the ther

Bone marrow transplantation for the therapy of refractory adult T cell acute lymphoblastic leukemia

✍ T. J. Garrett; E. Grossbard; S. Hopfan; B. Koziner; B. D. Clarkson; R. A. Good; 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB 👁 2 views

Two adult patients with T cell acute lymphoblastic leukemia (ALL) received an intensive multiagent therapeutic regimen and failed to enter remission. Following cytoreduction with cyclophosphamide (60 mg/kg x 2) and total body irradiation (1000 rads) they underwent bone marrow transplantation. One pa

Seamless anticoagulation therapy utilizi

Seamless anticoagulation therapy utilizing enoxaparin for acute coronary syndromes: Measure or not, here it comes!

✍ Marvin J. Slepian 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

Endothelial progenitor cell therapy for

Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: Current perspectives

✍ Michael R. Ward; Duncan J. Stewart; Michael J.B. Kutryk 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB 👁 2 views

Failure of fluconazole prophylaxis to re

Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia : Results of a prospective randomized Phase III study

✍ Wolfgang Kern; Gerhard Behre; Thomas Rudolf; Andrea Kerkhoff; Albert Grote-Metke 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 2 views

Invasive fungal infections have increasingly become a matter of concern with regard to patients receiving intensive myelosuppressive therapy for hematologic malignancies. Such infections, especially prolonged neutropenia systemic fungal infections, may contribute substantially to infectious complica